Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ulixacaltamide - Praxis Precision Medicine

Next Previous
Drug Profile

Ulixacaltamide - Praxis Precision Medicine

Alternative Names: PRAX-944; Z 944

Latest Information Update: 13 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zalicus
  • Developer Praxis Precision Medicines; Taro Pharmaceuticals USA
  • Class Analgesics; Antiepileptic drugs; Benzamides; Piperidines; Small molecules
  • Mechanism of Action T-type calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Essential tremor
  • Phase II Epilepsy
  • No development reported Pain

Most Recent Events

  • 04 Aug 2025 Praxis Precision Medicines completes enrolment in the phase III Essential 3 trial in Essential tremor in USA (PO)
  • 29 Feb 2024 Praxis Precision Medicines completes a phase II clinical trials in Essential tremor in Canada and USA (PO) (NCT05021991)
  • 05 Jan 2024 Ulixacaltamide licensed to Tenacia Biotechnology in China, Hong Kong, Macau and Taiwan

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top